Remove Blog Remove Efficacy & Potency Remove Regulations
article thumbnail

Do You Have a Combination Product, and Is It Drug-led or Device-led? Early Regulatory Insights

The Premier Consulting Blog

This blog post aims to bring clarity to this confusing subject for sponsors. e) reveals more detail — and gray areas: Two or more regulated components, in one package (e.g., e) reveals more detail — and gray areas: Two or more regulated components, in one package (e.g., therapeutic drug/monoclonal antibody) Drug/device (e.g.,